Skip to main content
Equibles

Farther Finance Advisors, LLC

Position in INCY — Incyte Corp

CIK 1992825 SAN FRANCISCO, CA
Back to INCY Full portfolio

Position in INCY

as of Sep 30, 2026 · filed Oct 8, 2026
Position Value
$1,123,215
+$917,694 QoQ
Shares Held
9,256
+410.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 23 holders
Holding Since
Dec 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in INCY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Sep 30, 2026

Farther Finance Advisors, LLC holds $27,307,338 across 327 Biotechnology names. INCY ranks #5 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 9,471 $4,951,533
2 MRNA
Moderna, Inc.
 17,622 $3,393,468
3 HALO
Halozyme Therapeutics, Inc.
 11,074 $1,222,569
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,534 $1,163,186
5 INCY
Incyte Corp
This page 		9,256 $1,123,215
6 EXEL
Exelixis, Inc.
 18,290 $1,068,318
7 RVMD
Revolution Medicines, Inc.
 4,848 $995,100
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 12,147 $795,021

All Filings in INCY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-09-30 $1,123,215 9,256
2026-06-30 $205,521 1,813
2026-03-31 $171,298 1,820
2025-12-31 $496,220 5,024
2025-09-30 $151,555 1,787
2025-06-30 $116,178 1,706
2025-03-31 $93,852 1,550
2024-12-31 $18,648 270
2024-09-30 $12,889 195
2024-06-30 $7,577 125
2024-03-31 $15,723 276
2023-12-31 $3,265 52
2023-09-30 $2,368 41
2023-06-30 $1,743 28
2023-03-31 $3,902 54
2022-12-31 $9,959 124